Cargando…
Association between uric acid lowering and renal function progression: a longitudinal study
BACKGROUND: This study aimed to explore the association between uric acid lowering and renal function. MATERIALS AND METHODS: We conducted a population-based cohort study with 1,534 subjects for 4 years from 2012 to 2016. The population was divided into four groups according to the interquartile ran...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000451/ https://www.ncbi.nlm.nih.gov/pubmed/33828916 http://dx.doi.org/10.7717/peerj.11073 |
_version_ | 1783671002831519744 |
---|---|
author | Liu, Liyi You, Lili Sun, Kan Li, Feng Qi, Yiqin Chen, Chaogang Wang, Chuan Lao, Guojuan Xue, Shengneng Tang, Juying Li, Na Feng, Wanting Yang, Chuan Xu, Mingtong Li, Yan Yan, Li Ren, Meng Lin, Diaozhu |
author_facet | Liu, Liyi You, Lili Sun, Kan Li, Feng Qi, Yiqin Chen, Chaogang Wang, Chuan Lao, Guojuan Xue, Shengneng Tang, Juying Li, Na Feng, Wanting Yang, Chuan Xu, Mingtong Li, Yan Yan, Li Ren, Meng Lin, Diaozhu |
author_sort | Liu, Liyi |
collection | PubMed |
description | BACKGROUND: This study aimed to explore the association between uric acid lowering and renal function. MATERIALS AND METHODS: We conducted a population-based cohort study with 1,534 subjects for 4 years from 2012 to 2016. The population was divided into four groups according to the interquartile range of changes in serum uric acid with quartile 1 representing lower quarter. Renal function decline was defined as eGFR decreased more than 10% from baseline in 2016. Renal function improvement was defined as eGFR increased more than 10% from baseline in 2016. Cox regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI). RESULTS: In the adjusted Cox regression models, compared to quartile 4, quartile 1 (HR = 0.64, 95% CI [0.49–0.85]), quartile 2 (HR = 0.65, 95% CI [0.50–0.84]) and quartile 3 (HR = 0.75, 95% CI [0.58–0.96]) have reduced risk of renal function decline. An increasing hazard ratio of renal function improvement was shown in quartile 1 (HR = 2.27, 95% CI [1.45–3.57]) and quartile 2 (HR = 1.78, 95% CI [1.17–2.69]) compared with quartile 4. CONCLUSIONS: Uric acid lowering is associated with changes in renal function. The management of serum uric acid should receive attention in clinical practice and is supposed to be part of the treatment of chronic kidney disease. |
format | Online Article Text |
id | pubmed-8000451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80004512021-04-06 Association between uric acid lowering and renal function progression: a longitudinal study Liu, Liyi You, Lili Sun, Kan Li, Feng Qi, Yiqin Chen, Chaogang Wang, Chuan Lao, Guojuan Xue, Shengneng Tang, Juying Li, Na Feng, Wanting Yang, Chuan Xu, Mingtong Li, Yan Yan, Li Ren, Meng Lin, Diaozhu PeerJ Diabetes and Endocrinology BACKGROUND: This study aimed to explore the association between uric acid lowering and renal function. MATERIALS AND METHODS: We conducted a population-based cohort study with 1,534 subjects for 4 years from 2012 to 2016. The population was divided into four groups according to the interquartile range of changes in serum uric acid with quartile 1 representing lower quarter. Renal function decline was defined as eGFR decreased more than 10% from baseline in 2016. Renal function improvement was defined as eGFR increased more than 10% from baseline in 2016. Cox regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI). RESULTS: In the adjusted Cox regression models, compared to quartile 4, quartile 1 (HR = 0.64, 95% CI [0.49–0.85]), quartile 2 (HR = 0.65, 95% CI [0.50–0.84]) and quartile 3 (HR = 0.75, 95% CI [0.58–0.96]) have reduced risk of renal function decline. An increasing hazard ratio of renal function improvement was shown in quartile 1 (HR = 2.27, 95% CI [1.45–3.57]) and quartile 2 (HR = 1.78, 95% CI [1.17–2.69]) compared with quartile 4. CONCLUSIONS: Uric acid lowering is associated with changes in renal function. The management of serum uric acid should receive attention in clinical practice and is supposed to be part of the treatment of chronic kidney disease. PeerJ Inc. 2021-03-24 /pmc/articles/PMC8000451/ /pubmed/33828916 http://dx.doi.org/10.7717/peerj.11073 Text en ©2021 Liu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Diabetes and Endocrinology Liu, Liyi You, Lili Sun, Kan Li, Feng Qi, Yiqin Chen, Chaogang Wang, Chuan Lao, Guojuan Xue, Shengneng Tang, Juying Li, Na Feng, Wanting Yang, Chuan Xu, Mingtong Li, Yan Yan, Li Ren, Meng Lin, Diaozhu Association between uric acid lowering and renal function progression: a longitudinal study |
title | Association between uric acid lowering and renal function progression: a longitudinal study |
title_full | Association between uric acid lowering and renal function progression: a longitudinal study |
title_fullStr | Association between uric acid lowering and renal function progression: a longitudinal study |
title_full_unstemmed | Association between uric acid lowering and renal function progression: a longitudinal study |
title_short | Association between uric acid lowering and renal function progression: a longitudinal study |
title_sort | association between uric acid lowering and renal function progression: a longitudinal study |
topic | Diabetes and Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000451/ https://www.ncbi.nlm.nih.gov/pubmed/33828916 http://dx.doi.org/10.7717/peerj.11073 |
work_keys_str_mv | AT liuliyi associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT youlili associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT sunkan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT lifeng associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT qiyiqin associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT chenchaogang associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT wangchuan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT laoguojuan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT xueshengneng associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT tangjuying associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT lina associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT fengwanting associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT yangchuan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT xumingtong associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT liyan associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT yanli associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT renmeng associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy AT lindiaozhu associationbetweenuricacidloweringandrenalfunctionprogressionalongitudinalstudy |